Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rad51 Recombinase | 10 | 2019 | 81 | 2.630 |
Why?
|
| Homologous Recombination | 6 | 2022 | 57 | 1.340 |
Why?
|
| Morpholines | 3 | 2015 | 61 | 0.770 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 641 | 0.770 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 3 | 0.750 |
Why?
|
| NF-kappa B | 1 | 2022 | 408 | 0.610 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 69 | 0.590 |
Why?
|
| Pyrroles | 4 | 2019 | 165 | 0.590 |
Why?
|
| Quinoxalines | 1 | 2019 | 51 | 0.580 |
Why?
|
| Escherichia coli Proteins | 3 | 2013 | 179 | 0.480 |
Why?
|
| Rec A Recombinases | 2 | 2013 | 14 | 0.470 |
Why?
|
| Escherichia coli | 2 | 2009 | 563 | 0.450 |
Why?
|
| DNA Repair | 6 | 2019 | 361 | 0.440 |
Why?
|
| DNA | 4 | 2019 | 1265 | 0.390 |
Why?
|
| Maleimides | 1 | 2012 | 27 | 0.390 |
Why?
|
| Nucleotides | 1 | 2009 | 93 | 0.300 |
Why?
|
| Molecular Structure | 3 | 2019 | 307 | 0.280 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 2303 | 0.280 |
Why?
|
| Neoplasms | 4 | 2016 | 3169 | 0.280 |
Why?
|
| Structure-Activity Relationship | 3 | 2019 | 422 | 0.260 |
Why?
|
| HEK293 Cells | 4 | 2019 | 696 | 0.250 |
Why?
|
| Hypoxanthine | 1 | 2006 | 4 | 0.250 |
Why?
|
| Protein Binding | 5 | 2019 | 1534 | 0.240 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 232 | 0.230 |
Why?
|
| DNA Helicases | 2 | 2015 | 89 | 0.210 |
Why?
|
| DNA Replication | 3 | 2019 | 168 | 0.190 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 72 | 0.180 |
Why?
|
| Cell Survival | 3 | 2019 | 1004 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 740 | 0.160 |
Why?
|
| Cycloaddition Reaction | 1 | 2019 | 6 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2019 | 27 | 0.140 |
Why?
|
| Pyrophosphatases | 2 | 2009 | 17 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 2755 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 410 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2009 | 352 | 0.130 |
Why?
|
| Benzamides | 2 | 2015 | 246 | 0.120 |
Why?
|
| Humans | 12 | 2022 | 93515 | 0.120 |
Why?
|
| Sulfonamides | 2 | 2015 | 331 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2019 | 396 | 0.110 |
Why?
|
| Mutation | 1 | 2006 | 4272 | 0.110 |
Why?
|
| HIV-1 | 1 | 2015 | 173 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2014 | 68 | 0.100 |
Why?
|
| Fluorometry | 1 | 2013 | 30 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1234 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1338 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 100 | 0.090 |
Why?
|
| Mitomycin | 1 | 2012 | 29 | 0.090 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 89 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2012 | 120 | 0.090 |
Why?
|
| Meiosis | 1 | 2012 | 84 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 111 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2022 | 3502 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 145 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 419 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1660 | 0.080 |
Why?
|
| DNA Damage | 1 | 2012 | 389 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 1133 | 0.080 |
Why?
|
| Suppression, Genetic | 1 | 2009 | 30 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 409 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 299 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 460 | 0.070 |
Why?
|
| Nitrous Acid | 1 | 2006 | 1 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 67 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 150 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 273 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 275 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 120 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1741 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 116 | 0.040 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2015 | 18 | 0.030 |
Why?
|
| Stilbenes | 1 | 2015 | 26 | 0.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2015 | 26 | 0.030 |
Why?
|
| Mutagens | 1 | 2015 | 29 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2015 | 16 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2015 | 45 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 106 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 266 | 0.030 |
Why?
|
| Virus Replication | 1 | 2015 | 284 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2014 | 88 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 399 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 555 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 379 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 12269 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1721 | 0.020 |
Why?
|
| Recombinases | 1 | 2012 | 22 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 2012 | 60 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 824 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2012 | 98 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1914 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2012 | 95 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 65 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 246 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2464 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1301 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 342 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 440 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1353 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 28155 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3911 | 0.010 |
Why?
|